EXACT SCIENCES HIGHLIGHTS THE OPPORTUNITY TO SEEK SCREENING WITH COLOGUARD® THROUGH TELEHEALTH

FIGHT COLORECTAL CANCER RECEIVES GRANT FROM EXACT SCIENCES TO LAUNCH PROGRAM AIMED AT REDUCING PATIENT BARRIERS TO COLORECTAL CANCER SCREENING

New Evidence from Large Studies Highlights Value of Oncotype DX Breast Recurrence Score® to Guide Chemotherapy Treatment in Young Patients with Node-Negative or Node-Positive Early-Stage Breast Cancer

Dr. David Ahlquist, Co-Inventor of Cologuard, Named a Fellow of the National Academy of Inventors

Exact Sciences Completes Combination with Genomic Health, Creating Leading Global Cancer Diagnostics Company

Exact Sciences Presents Data on Blood-based Test for Detection of Hepatocellular Carcinoma, Earns FDA Breakthrough Device Designation

Exact Sciences Presents New Stool-based Colorectal Cancer Screening Performance Data, Initiates Prospective Screening Study

PGA Tour Champions and Exact Sciences Announce Five-year Extension of Cologuard Classic

Cologuard® Gains FDA Approval for Use in Younger Americans, Ages 45 to 49

Exact Sciences Named One of the 2019 Best Workplaces for Women by Great Place to Work and Fortune

Cologuard® Helps More People Get Screened In A Cost-Effective Way

Exact Sciences And Genomic Health To Combine, Creating Leading Global Cancer Diagnostics Company